Letters
β blockers and mortality in COPD
Major changes in practice and interpreting data from the past
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1131 (Published 29 January 2014) Cite this as: BMJ 2014;348:g1131
- Filippo Sanfilippo, senior clinical fellow in cardiac intensive care1,
- Cristina Santonocito, senior clinical fellow in cardiac intensive care1,
- Pierre Foex, professor of anaesthesia (retired)1
- 1John Radcliffe Hospital, Oxford OX3 9DU, UK
- filipposanfi{at}yahoo.it
Quint and colleagues recently published the results of their investigation into the role of β blockers in patients with chronic obstructive pulmonary disease (COPD) having a first myocardial infarction.1 They obtained data from the UK national registry of myocardial infarction between 2003 and 2008. The primary outcome of all …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.